Bioscience summit planned for Feb. 28 in Charleston
CHARLESTON -- The Bioscience Association of West Virginia's 3rd Annual West Virginia Bioscience Summit is planned for 8 a.m. to 4:30 p.m. Thursday, Feb. 28, at the Town Center Marriott Hotel in Charleston.
A host of industry leaders, policy makers and experts will participate in the conference. Among them will be Dave Scholl, who helped grow Athens, Ohio-based Diagnostic Hybrids into a $100 million biotech company. He is now a partner in a regional venture capital firm and involved with the billion dollar Third Frontier Program in Ohio. He, along with 20-plus other life science experts, will share experiences and discuss strategies West Virginia can implement to successfully grow discoveries and the bioscience industry.
The event will feature panel discussions with university researchers and representatives to highlight the breadth of research being conducted in the state and to discuss the challenges of raising capital and policies that may help.
The event is being sponsored by the Biotechnology Industry Organization (BIO), Pharmaceutical Research & Manufacturers of America (PhRMA), Mylan, Pfizer, Fisher Scientific, Amgen, Steptoe & Johnson, Blanchette Rockefeller Neurosciences Institute, WV Small Business Development Center and TechConnect West Virginia.
BioWV also receives funding through a grant by the Claude Worthington Benedum Foundation.
To register for the event, visit www.biowv.org and click on the "events" link.
The Herald-Dispatch welcomes your comments on this article, but please be civil. Avoid profanity, obscenity, personal attacks, accusations of criminal activity, name-calling or insults to the other posters. Herald-dispatch.com does not control or monitor comments as they are posted, but if you find a comment offensive or uncivil, hover your mouse over the comment and click the X that appears in the upper right of the comment. If you do not want your comment to post to your personal Facebook page, uncheck the box below the comment.